Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models

Stem Cells
Garima KaushikSurinder K Batra

Abstract

Three-dimensional (3D) cultures use the property of some cells to self-organize in matrices and generate structures that can be programmed to represent an organ or a pathology. Organoid cultures are the 3D cultivation of source tissue (ranging from cells to tissue fragments) in a support matrix and specialized media that nearly resembles the physiological environment. Depending on the source tissue, growth factors, and inhibitors provided, organoids can be programmed to recapitulate the biology of a system and progression of pathology. Organoids are genetically stable, and genetically amenable, making them very suitable tools to study tissue homeostasis and cancer. In this Review, we focus on providing recent technical advances from published literature to efficiently use organoids as a tool for disease modeling and therapeutics. Also, we discuss stem cell biology principles used to generate multiple organoids and their characteristics, with a brief description of methodology. A major theme of this review is to expand organoid applications to the study disease progression and drug response in different cancers. We also discuss shortcomings, limitations, and advantages of developed 3D cultures, with the rationale behind the meth...Continue Reading

References

Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Robert BalsThierry Chinet
May 11, 2006·Differentiation; Research in Biological Diversity·Melville B VaughanJerry W Shay
Jan 24, 2008·The Prostate·Kenneth J PientaRobert L Vessella
Jul 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yanan DuAli Khademhosseini
Feb 21, 2009·PLoS Genetics·Andrew W DuncanMarkus Grompe
Apr 17, 2009·Development·J Sawalla GusehJayaraj Rajagopal
Nov 7, 2009·Respiratory Research·Lindsey Van HauteMartine De Rycke
Jan 1, 2010·Trends in Biotechnology·Tandis Vazin, David V Schaffer
Jan 7, 2010·The Journal of Clinical Investigation·Raheem Peerani, Peter W Zandstra
Feb 18, 2010·Proteomics·Chris S HughesGilles A Lajoie
Mar 2, 2011·Nature Biotechnology·Michael D GreenHans-Willem Snoeck
Sep 6, 2011·Nature Medicine·Peter JungEduard Batlle
Jun 19, 2012·Cell Stem Cell·Tokushige NakanoYoshiki Sasai
Oct 26, 2012·Methods in Molecular Biology·Rana Mroue, Mina J Bissell
Jan 17, 2013·Current Gene Therapy·Emilie Bayart, Odile Cohen-Haguenauer
Apr 30, 2013·Biochemical Pharmacology·Anton Kuratnik, Charles Giardina
Jun 4, 2013·Nature Medicine·Johanna F DekkersJeffrey M Beekman
Sep 3, 2013·Nature·Madeline A LancasterJuergen A Knoblich
Dec 4, 2013·European Journal of Pediatrics·Johannes I WiegerinckPeter A A Struijs
Mar 25, 2014·Current Opinion in Genetics & Development·Norman Sachs, Hans Clevers
May 23, 2014·Nature Materials·William L MurphyAdam J Engler
Jul 19, 2014·Science·Madeline A Lancaster, Juergen A Knoblich
Aug 6, 2014·Nature Biotechnology·Sean V Murphy, Anthony Atala
Sep 23, 2014·Nature Cell Biology·Chee Wai ChuaMichael M Shen
Jan 6, 2015·Cell·Sylvia F BojDavid A Tuveson
Mar 18, 2015·Annals of Biomedical Engineering·Aleksander SkardalShay Soker

❮ Previous
Next ❯

Citations

Mar 30, 2019·Proceedings of the National Academy of Sciences of the United States of America·Amanda MarchiniFabrizio Gelain
Feb 23, 2020·Drug Metabolism Reviews·Neha MaharaoJyotika Varshney
Mar 19, 2020·Biomolecules·Susana M Chuva de Sousa LopesGudrun Valdimarsdottir
May 21, 2020·SLAS Discovery·Stephan SteigeleStephan Heyse
Jul 14, 2020·Frontiers in Bioengineering and Biotechnology·Zhitong ZhaoKee Woei Ng
Jul 24, 2020·Cellular and Molecular Life Sciences : CMLS·Luis A CostaFrancisco J Vizoso
Feb 12, 2020·Journal of Personalized Medicine·Chiara ArgentatiSabata Martino
Sep 27, 2020·Cancers·Zarema GilazievaValeriya Solovyeva
Apr 28, 2019·International Journal of Molecular Sciences·Alicja M NogackaSonia González
Mar 15, 2019·Journal of Experimental & Clinical Cancer Research : CR·Claudia ChiodoniKatia Scotlandi
Mar 3, 2020·Nanoscale Horizons : the Home for Rapid Reports of Exceptional Significance in Nanoscience and Nanotechnolgy·Emilie DarriguesAnaliz Rodriguez
Sep 2, 2020·Diseases of the Colon and Rectum·Reece K DeHaanEmina H Huang
Nov 13, 2020·Tissue Engineering and Regenerative Medicine·James J YooInho Jo
Nov 27, 2020·Frontiers in Cell and Developmental Biology·Margaret S BohmJason R Spence
Nov 21, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fan LeiTatiana K Bronich
Mar 7, 2021·Cancers·Sreenivasulu GuntiNyall R London
Mar 1, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Sanchita RauthMoorthy P Ponnusamy
Mar 9, 2020·Current Opinion in Genetics & Development·Mingyuan Zhu, Adrienne Hk Roeder
Apr 4, 2021·International Journal of Molecular Sciences·Gianluca CostamagnaStefania Corti
Apr 21, 2021·The FEBS Journal·Michael Dannemann, Irene Gallego Romero
May 25, 2021·Chemical Reviews·Yuxiao LiuYuanjin Zhao
Jul 3, 2021·Biomolecules·Oliwia KoszłaAgnieszka A Kaczor
Aug 3, 2021·Frontiers in Cell and Developmental Biology·Hongyu LiZhaohui Li
Aug 6, 2021·Advanced Science·Alessandra DellaquilaTeresa Simon-Yarza
Sep 22, 2021·Cellular and Molecular Gastroenterology and Hepatology·Min-Jiao PangZhen-Ning Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.